Prof Says Ex-SAC Manager Got Details On Drug Study

Law360, New York (January 21, 2014, 8:46 PM EST) -- A former university professor testified Tuesday that he provided ex-SAC Capital Advisors LP portfolio manager Mathew Martoma final details on an Alzheimer’s drug study, expanding on testimony he offered in Manhattan federal court last week.

Sidney Gilman told jurors that he provided Martoma with the final safety committee report on a the drug bapineuzumab, building on testimony he offered Friday.

Gilman, a former University of Michigan professor who chaired the drug’s safety committee, is widely considered the star witness in the case against Martoma, a former...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.